Bed Bath & Beyond Hits Multiyear Low After Earnings

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Bed Bath & Beyond Hits Multiyear Low After Earnings

© Thinkstock

Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported its fiscal first-quarter financial results after the markets closed Thursday, and as a result the stock hit a multiyear low. In fact, shares have not been at this level in seven years.

The company said that it had $0.58 in earnings per share (EPS) and $2.74 billion in revenue. That compared with Thomson Reuters consensus estimates of $0.66 in EPS and $2.79 billion in revenue.

Comparable sales in the quarter fell by roughly 2.0%, compared with a decrease of about 0.5% in last year’s fiscal first quarter. Comparable sales from customer-facing digital channels continued to have strong growth in excess of 20%, while comparable sales from stores declined in the mid-single-digit percentage range during the fiscal 2017 first quarter.

During the fiscal 2017 first quarter, Bed Bath & Beyond repurchased $127 million worth of its common stock, representing about 3.3 million shares, under its existing $2.5 billion share repurchase program. At the end of this quarter, the program had a remaining balance of $1.6 billion.

[nativounit]

Bed Bath & Beyond detailed in its earnings release:

Although the first quarter is typically the least impactful quarter in terms of annual sales and earnings, and while the Company continued to have strong growth in its customer-facing-digital channels this quarter, the Company did experience increased softness in transactions in stores, as well as higher net-direct-to-customer shipping expense, coupon expense, and advertising costs during the quarter.  It remains to be seen whether these challenges were more pronounced in, or unique to, the first quarter due to the smaller sales base in this period, and/or a later start to the summer selling period.

On the books, Bed Bath & Beyond cash, cash equivalents and short-term investments totaled $469.32 million at the end of the quarter, down from $566.8 million in the same period from last year.

Shares of Bed Bath & Beyond closed Thursday at $33.73, with a consensus analyst price target of $38.00 and a 52-week range of $33.40 to $48.83. Following the release, the stock was down more than 10% at $30.19 in early trading indications Friday.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

DELL Vol: 42,366,555
NTAP Vol: 15,911,807
NOW Vol: 68,243,561
IBM
IBM Vol: 28,527,546
HPE Vol: 86,996,387

Top Losing Stocks

CTRA Vol: 73,319,495
CLX Vol: 4,744,001
RMD Vol: 3,526,686
INTC Vol: 191,680,425
SWKS Vol: 5,407,806